BRIEF

on BLUELINEA (EPA:ALBLU)

Bluelinea is projecting 9% growth in 2025

Stock price chart of BLUELINEA (EPA:ALBLU) showing fluctuations.

In 2025, Bluelinea, a key player in the French "Silver Economy," achieved unaudited revenue of €10,271,000, representing a 9% increase compared to the previous year. This growth was primarily driven by B2B activity in healthcare facilities, which saw a 30% increase, fueled by the success of the Serenea® solution. This strong performance offset a slight 3% decline in B2C activity targeting seniors and their home care needs.

The B2C sector remains the main contributor with €5,930k, despite intense competition. Bluelinea is focusing on optimizing its sales and leveraging synergies with the APICIL Group to relaunch its growth. The B2B division benefited from renewed investment in the senior living sector, coupled with significant contracts, enabling installations at 776 sites by the end of 2025. To strengthen its governance, the company has welcomed new executives to its Management Board.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BLUELINEA news